BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18412021)

  • 21. Effect of oleic, lauric and myristic acids on phenylephrine-induced contractions of isolated rat vas deferens.
    Arruzazabala ML; Pérez Y; Ravelo Y; Molina V; Carbajal D; Mas R; Rodríguez E
    Indian J Exp Biol; 2011 Sep; 49(9):684-8. PubMed ID: 21941942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of saw palmetto extract on micturition reflex of rats and its autonomic receptor binding activity.
    Oki T; Suzuki M; Nishioka Y; Yasuda A; Umegaki K; Yamada S
    J Urol; 2005 Apr; 173(4):1395-9. PubMed ID: 15758812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-004, a lipid extract from royal palm fruit, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice.
    Carbajal D; Ravelo Y; Molina V; Mas R; Arruzazabala Mde L
    Pharmacol Biochem Behav; 2009 May; 92(3):465-8. PubMed ID: 19463260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term (24 Months) Carcinogenicity Study of D-004, a Lipid Extract From Roystonea regia Fruits, in Sprague Dawley Rats.
    Gutiérrez A; Gámez R; Noa M; Mas R; Valle M; Mendoza N; Nodal C; Pérez Y; Oyarzábal Á; Bucarano I; Goicochea E; Jiménez S; García H
    Int J Toxicol; 2015; 34(2):138-50. PubMed ID: 25823441
    [No Abstract]   [Full Text] [Related]  

  • 25. [Duration of action of silodosin (KMD-3213) against phenylephrine-induced increase in intraurethral pressure in rats].
    Kobayashi M; Tatemichi S; Kobayashi K; Imamura T; Maruyama I; Yamazaki Y; Shibata N
    Yakugaku Zasshi; 2006 Mar; 126 Spec no.():231-6. PubMed ID: 16518088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral subchronic toxicity of a lipid extract from Roystonea regia fruits in mice.
    Gutiérrez A; Gámez R; Mas R; Noa M; Pardo B; Marrero G; Pérez Y; González R; Curveco D; García H
    Drug Chem Toxicol; 2008; 31(2):217-28. PubMed ID: 18330783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition by tamsulosin of tension responses of human hyperplastic prostate to electrical field stimulation.
    Chueh SC; Guh JH; Chen J; Lai MK; Ko FN; Teng CM
    Eur J Pharmacol; 1996 Jun; 305(1-3):177-80. PubMed ID: 8813550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of D-004, a lipid extract from Cuban royal palm fruit, on inhibiting prostatic hypertrophy induced with testosterone or dihydrotestosterone in a rat model: A randomized, controlled study.
    Carbajal D; Arruzazabala Mde L; Rosa M; Molina V; Rodríguez E; González V
    Curr Ther Res Clin Exp; 2004 Nov; 65(6):505-14. PubMed ID: 24672102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulatory effect of phenylephrine on the secretion of beta-endorphin from rat adrenal medulla in vitro.
    Cheng JT; Liu IM; Kuo DH; Lin MT
    Auton Neurosci; 2001 Oct; 93(1-2):31-5. PubMed ID: 11695703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saw palmetto and benign prostatic hyperplasia.
    Gong EM; Gerber GS
    Am J Chin Med; 2004; 32(3):331-8. PubMed ID: 15344416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tamsulosin and chlormadinone for the treatment of benign prostatic hyperplasia. The Kobe University YM617 Study Group.
    Okada H; Kawaida N; Ogawa T; Arakawa S; Matsumoto O; Kamidono S
    Scand J Urol Nephrol; 1996 Oct; 30(5):379-85. PubMed ID: 8936627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo.
    Fukuta Y; Fukuda Y; Higashino R; Yoshida K; Ogishima M; Tamaki H; Takei M
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1013-8. PubMed ID: 10454472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonistic effects of selective alpha1-adrenoceptor antagonists MDL73005EF and tamsulosin and partial agonists clonidine and tizanidine in rat thoracic aorta and rabbit iliac artery.
    Satoh M; Enomoto K; Koike K
    J Pharm Pharmacol; 2001 Jan; 53(1):103-8. PubMed ID: 11206183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride.
    Zlotta AR; Teillac P; Raynaud JP; Schulman CC
    Eur Urol; 2005 Aug; 48(2):269-76. PubMed ID: 15939527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential vascular alpha1-adrenoceptor antagonism by tamsulosin and terazosin.
    Schäfers RF; Fokuhl B; Wasmuth A; Schumacher H; Taguchi K; de Mey C; Philipp T; Michel MC
    Br J Clin Pharmacol; 1999 Jan; 47(1):67-74. PubMed ID: 10073742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia.
    Yamada S; Ohkura T; Kimura R; Kawabe K
    Life Sci; 1998; 62(17-18):1585-9. PubMed ID: 9585140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of alpha1-adrenoceptor occupancy in the human prostate from plasma concentrations of silodosin, tamsulosin and terazosin to treat urinary obstruction in benign prostatic hyperplasia.
    Yamada S; Kato Y; Okura T; Kagawa Y; Kawabe K
    Biol Pharm Bull; 2007 Jul; 30(7):1237-41. PubMed ID: 17603160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased contractile response to phenylephrine in detrusor of patients with bladder outlet obstruction: effect of the alpha1A and alpha1D-adrenergic receptor antagonist tamsulosin.
    Bouchelouche K; Andersen L; Alvarez S; Nordling J; Bouchelouche P
    J Urol; 2005 Feb; 173(2):657-61. PubMed ID: 15643283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of silodosin (KMD-3213) on phenylephrine-induced increase in intraurethral pressure and blood pressure in rats--study of the selectivity for lower urinary tract].
    Tatemichi S; Kobayashi K; Maruyama I; Kobayashi M; Yamazaki Y; Shibata N
    Yakugaku Zasshi; 2006 Mar; 126 Spec no.():217-23. PubMed ID: 16518086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.